SCHEMBL21019486

SCHEMBL21019486

C/C=c1\c(=C/C)n2c3ccccc3nc2c2c1ccc1ccccc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 8/20 0.43
▸ MAPT P10636 5/20 0.43
▸ HSD17B10 Q99714 5/20 0.43
▸ LMNA P02545 4/20 0.43
▸ POLB P06746 4/20 0.43
▸ TP53 P04637 2/20 0.43
▸ ALDH1A1 P00352 7/20 0.40
▸ HPGD P15428 7/20 0.40
▸ KMT2A Q03164 6/20 0.40
▸ MEN1 O00255 4/20 0.40
▸ TSHR P16473 3/20 0.39
▸ CASP1 P29466 2/20 0.39
▸ CASP7 P55210 2/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ ATM Q13315 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ BCL2 P10415 1/20 0.37
▸ CAMKK1 Q8N5S9 2/20 0.37
▸ CAMKK2 Q96RR4 2/20 0.37
▸ CSNK2A2 P19784 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19606221 0.84 KDM4E (0.53) KDM4EMAPTHSD17B10LMNAPOLB
SCHEMBL18118550 0.78 KDM4E (0.47) KDM4EMAPTHSD17B10LMNAPOLB
SCHEMBL19959758 0.76 KDM4E (0.46) KDM4EMAPTHSD17B10LMNAPOLB
SCHEMBL19959761 0.76 KDM4E (0.46) KDM4EMAPTHSD17B10LMNAPOLB
SCHEMBL21297843 0.75 MAPT (0.48) KDM4EMAPTHSD17B10LMNAPOLB
SCHEMBL21297966 0.74 KDM4E (0.44) KDM4EMAPTHSD17B10LMNAPOLB
SCHEMBL21297838 0.73 KDM4E (0.47) KDM4EMAPTHSD17B10LMNAPOLB
SCHEMBL19959760 0.73 KDM4E (0.43) KDM4EMAPTHSD17B10LMNAPOLB
SCHEMBL18659157 0.73 KDM4E (0.47) KDM4EMAPTHSD17B10LMNAPOLB
SCHEMBL21298237 0.72 KDM4E (0.42) KDM4EMAPTHSD17B10LMNAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10995098-B2 Heterocyclic compound and organic light emitting device comprising the same LG CHEM, LTD. (KR) 2021-05-04 — — US disclosed
US-20190152985-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME LG CHEM, LTD. (KR) 2019-05-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190152985-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME CRY1, CYP1A1, CYP1B1 KDM4E 2427/4885MAPT 1550/4885HSD17B10 956/4885
US-10995098-B2 Heterocyclic compound and organic light emitting device comprising the same CRY1, CYP1A1, CYP1B1 KDM4E 2427/4885MAPT 1550/4885HSD17B10 956/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback